Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02310230
What this trial is testing

An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy

Who this might be right for
Biliary Tract DiseasesStomach NeoplasmsCarcinoma, Pancreatic Ductal+1 more
Donald Mathews 100
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT07432295
What this trial is testing

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+3 more
I-Mab Biopharma US Limited 180
Not applicableActive Not RecruitingNCT04314401
What this trial is testing

National Cancer Institute "Cancer Moonshot Biobank"

Who this might be right for
Acute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more
National Cancer Institute (NCI) 1,600
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT06251973
What this trial is testing

AgenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

Who this might be right for
Metastatic Esophageal CarcinomaAdvanced Unresectable Gastric AdenocarcinomaMetastatic Gastric Cancer+10 more
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06846346
What this trial is testing

Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma

Who this might be right for
Metastatic Esophageal AdenocarcinomaAdvanced Esophageal AdenocarcinomaMetastatic Gastric Adenocarcinoma+1 more
UNICANCER 88
Testing effectiveness (Phase 2)Ended earlyNCT01262183
What this trial is testing

Radio-chemotherapy With or Without Panitumumab (Vectibix®) in Irresectable Squamous Cell Carcinoma or Adenocarcinoma of the Oesophagus

Who this might be right for
Irresectable Squamous Cell or Adenocarcinoma of the Oesophagus
Radboud University Medical Center 4
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Not applicableStudy completedNCT02776982
What this trial is testing

Influence of Central Obesity on the Esophageal Epithelial Barrier

Who this might be right for
Gastroesophageal RefluxGERD
Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00215462
What this trial is testing

Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma

Who this might be right for
Esophageal CancerGastric CancerStomach Cancer
Dana-Farber Cancer Institute 32
Early research (Phase 1)Looking for participantsNCT04900818
What this trial is testing

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+5 more
I-Mab Biopharma US Limited 330
Not applicableStudy completedNCT04501913
What this trial is testing

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

Who this might be right for
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage 0 Gastric Cancer AJCC v8+169 more
City of Hope Medical Center 22
Early research (Phase 1)Active Not RecruitingNCT05799274
What this trial is testing

Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Healthy VolunteersPancreatic Ductal AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+4 more
Radiopharm Theranostics, Ltd 9
Not applicableStudy completedNCT00628368
What this trial is testing

Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer

Who this might be right for
Colorectal CancerEsophageal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 160
Not applicableStudy completedNCT02812680
What this trial is testing

The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal Adenocarcinoma

Who this might be right for
Esophageal Cancer
University Health Network, Toronto 84
Not applicableLooking for participantsNCT07714538
What this trial is testing

Breath Research Narrow Validation for Gastrointestinal Cancer Detection

Who this might be right for
Oesophageal Squamous Cell CarcinomaOesophageal AdenocarcinomaGastric Adenocarcinoma+4 more
Imperial College London 1,000
Testing effectiveness (Phase 2)UnknownNCT00005876
What this trial is testing

Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery

Who this might be right for
Esophageal CancerGastric Cancer
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT01512589
What this trial is testing

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

Who this might be right for
Esophageal Cancer
M.D. Anderson Cancer Center 147
Not applicableStudy completedNCT02305043
What this trial is testing

Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer

Who this might be right for
Esophageal NeoplasmsStomach Neoplasms
University of Leipzig 549
Next Page